Results 121 to 130 of about 24,637 (218)

Sex‐Specific Associations of Inflammatory Biomarkers With All‐Cause and Cardiovascular Mortality Across Glycaemic Status: A Prospective UK Biobank Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4728-4740, June 2026.
ABSTRACT Aims To explore sex‐specific heterogeneity in the prognostic discrimination of inflammatory markers for mortality across different glycaemic states. Methods This prospective cohort study included 450 438 participants from the UK Biobank (median follow‐up: 15.3 years), stratified by sex and glycaemic status.
Yawen Zhang, Menghan Li, Manrong Xu, Yun Shen, Lianxi Li, Gang Hu   +5 more
wiley   +1 more source

Polypharmacy and Bone Health in Patients with Type 2 Diabetes Mellitus: A Narrative Review. [PDF]

J Bone Metab
Kashmoola IO, Mohammad SH, Alsaaty MH.
europepmc   +1 more source

Association of GLP‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4837-4846, June 2026.
ABSTRACT Aims To evaluate the association between glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) initiation and the risk of hepatic decompensation compared with dipeptidyl peptidase 4 inhibitors (DPP4is) in a racially and ethnically diverse cohort of adults with Type 2 diabetes.
Inyoung Hwang, Yun Kim, Sang Won Lee
wiley   +1 more source

From diabetes to tumor growth: unravelling the impact of glucose-lowering therapies. [PDF]

Endocrine
Modica R, Liccardi A, Zamponi V, Gagliardi A, Nistor A, Veroi G, Arecco A, Faggiano A, Colao A.   +8 more
europepmc   +1 more source

Dementia Risk in Type 1 and 2 Diabetes: A Nationwide Population‐Based Comparison

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4915-4925, June 2026.
ABSTRACT Aims Diabetes is increasingly recognised as a major contributor to cognitive decline and dementia, but the risk varies by diabetes type and treatment intensity. We compared the risk of all‐cause dementia, Alzheimer's disease (AD) and vascular dementia (VaD) among individuals with and without diabetes.
Ji Eun Jun, Seohyun Kim, In‐Kyung Jeong, Jae Hyeon Kim   +3 more
wiley   +1 more source

Incidence and risk factors for osteoporosis in people with type 2 diabetes mellitus in Thailand. [PDF]

BMC Endocr Disord
Sribenjalak D, Looareesuwan P, Siriyotha S, Sritara C, Amnuaywattakorn S, Ongphiphadhanakul B, Thakkinstian A, Nimitphong H.   +7 more
europepmc   +1 more source

Waist‐to‐Height Ratio and the Risk of Cardiovascular Outcomes and Mortality in Type 2 Diabetes With and Without Abdominal Obesity

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4949-4960, June 2026.
ABSTRACT Aim Waist‐to‐height ratio (WHtR) has been suggested as a superior marker of cardiometabolic risk compared to waist circumference (WC), but evidence in type 2 diabetes mellitus (T2DM) remains limited. Materials and Methods A population‐based cohort of 2 076 104 patients with T2DM who underwent the Korean national health checkup between 2015 and
Kye‐Yeung Park, Kyungdo Han, Jung Hwan Park, Chang Beom Lee, Hoon‐Ki Park, Hwan‐Sik Hwang, Sangmo Hong, Sung Hoon Yu   +7 more
wiley   +1 more source

Sodium-glucose co-transporter 2 inhibitors are negatively correlated with hypomagnesemia in elderly patients with type 2 diabetes. [PDF]

Front Nutr
Lin L, Jin Y, Jin L, Wang B, Xu J, Chen S.   +5 more
europepmc   +1 more source

Use of Oral Semaglutide and Associated Clinical Outcomes in Thai Patients With Type 2 Diabetes: Real‐World Evidence From the REALISED Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5058-5067, June 2026.
ABSTRACT Aims The REALISED study assessed the clinical outcomes associated with oral semaglutide use in Thai patients with type 2 diabetes (T2D) in real‐world clinical settings. Materials and Methods This retrospective, multi‐centre cohort study included 195 patients with T2D initiating oral semaglutide between April 2022 and December 2023.
Taweesak Wannachalee, Pimjai Anthanont, Supamas Sirisreetreerux, Gurudutt Nayak, Woralak Chumchujan, Yodying Iamsudjai, Supawan Buranapin   +6 more
wiley   +1 more source

Intracellular Pharmacokinetics of Antidiabetic Drugs: A Focused Narrative Review of Subcellular Distribution (2015-2025). [PDF]

Diseases
Bafail DA.
europepmc   +1 more source